This builds on previous work that has characterised a role for BCL-3 in promoting tumour survival, inhibiting apoptosis through the AKT pathway [15], HDM2 [39], [42], [43] and DNA-PK [39]. The gene discussed is BCL3; the disease is neoplasm.